JP Stock MarketDetailed Quotes

3540 CI Medical

Watchlist

1280
+30+2.40%

20min DelayMarket Closed Sep 27 15:00 JST

64.00BMarket Cap30.73P/E (Static)

CI Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

10.47%12.37B

8.61%11.95B

6.38%45.63B

4.88%11.98B

9.01%11.45B

6.18%11.2B

5.59%11B

4.09%42.89B

7.71%11.42B

3.13%10.51B

Cost of revenue

13.04%9.18B

9.43%8.91B

7.74%33.63B

4.42%8.98B

9.04%8.38B

6.56%8.12B

11.50%8.15B

5.47%31.22B

10.60%8.6B

4.07%7.69B

Gross profit

3.64%3.19B

6.28%3.03B

2.76%11.99B

6.23%3B

8.91%3.07B

5.27%3.08B

-8.33%2.85B

0.58%11.67B

-0.21%2.82B

0.64%2.82B

Operating expense

24.81%2.61B

27.01%2.62B

17.22%9B

27.52%2.56B

16.26%2.29B

10.63%2.09B

13.77%2.07B

8.47%7.68B

7.97%2.01B

9.76%1.97B

Operating profit

-41.40%576M

-48.22%407M

-25.08%2.99B

-46.02%441M

-8.13%780M

-4.56%983M

-39.31%786M

-11.78%3.99B

-15.86%817M

-15.61%849M

Net non-operating interest income (expenses)

0.00%1M

-40.00%3M

-20.00%20M

0.00%3M

266.67%11M

-85.71%1M

-58.33%5M

19.05%25M

0.00%3M

-50.00%3M

Non-operating interest income

250.00%14M

28.57%9M

19.35%37M

66.67%10M

166.67%16M

-42.86%4M

-41.67%7M

47.62%31M

100.00%6M

0.00%6M

Non-operating interest expense

333.33%13M

200.00%6M

183.33%17M

133.33%7M

--5M

--3M

--2M

--6M

--3M

----

Net investment income

-1,500.00%-14M

59.26%-11M

13.33%-13M

266.67%11M

-71.43%2M

104.35%1M

-1,250.00%-27M

-287.50%-15M

150.00%3M

40.00%7M

Gain(Loss) on financial instruments designated as cash flow hedges

200.00%164M

-6M

103M

67M

-164M

Gain(Loss) on derecognition of available-for-sale financial assets

-47.83%-34M

54.05%-17M

-62.16%-60M

-64.29%-23M

-37M

64.76%-37M

23.33%-23M

Income from associates and other participating interests

-13M

-9M

51M

Special income (charges)

-2M

-51M

Less:Other special charges

--2M

---3M

--51M

----

Other non-operating income (expenses)

14.29%16M

-20.00%16M

54.72%82M

111.76%36M

-47.83%12M

100.00%14M

233.33%20M

8.16%53M

142.86%17M

130.00%23M

Income before tax

-51.07%528M

-51.72%393M

-17.32%3.18B

-24.42%492M

-9.41%799M

7.26%1.08B

-37.96%814M

-10.13%3.85B

-29.62%651M

-11.98%882M

Income tax

-48.64%189M

-51.85%143M

-18.25%1.08B

-36.61%142M

-11.22%277M

5.75%368M

-32.81%297M

-9.43%1.33B

-28.66%224M

-9.04%312M

Net income

-52.53%338M

-51.55%250M

-16.84%2.1B

-17.84%350M

-8.60%521M

8.04%712M

-40.62%516M

-10.50%2.52B

-30.28%426M

-13.51%570M

Net income continuous operations

-52.32%339M

-51.64%250M

-16.83%2.1B

-18.03%350M

-8.42%522M

8.05%711M

-40.57%517M

-10.49%2.53B

-30.11%427M

-13.51%570M

Noncontrolling interests

60.00%8M

150.00%2M

633.33%16M

333.33%7M

-4M

-3M

Net income attributable to the company

-53.19%330M

-52.59%247M

-17.41%2.08B

-18.91%343M

-10.00%513M

6.98%705M

-40.05%521M

-10.60%2.52B

-30.77%423M

-13.51%570M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-53.19%330M

-52.59%247M

-17.41%2.08B

-18.91%343M

-10.00%513M

6.98%705M

-40.05%521M

-10.60%2.52B

-30.77%423M

-13.51%570M

Gross dividend payment

Basic earnings per share

-53.24%6.598

-52.48%4.952

-17.41%41.654

-18.98%6.864

-9.92%10.26

6.99%14.11

-40.05%10.42

-10.61%50.432

-30.75%8.472

-13.58%11.39

Diluted earnings per share

-53.21%6.598

-52.48%4.952

-17.41%41.654

-18.91%6.8601

-9.92%10.26

6.98%14.1002

-40.05%10.42

-10.61%50.432

-30.77%8.4601

-13.58%11.39

Dividend per share

0.00%5.044

-10.60%5.044

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	10.47%12.37B	8.61%11.95B	6.38%45.63B	4.88%11.98B	9.01%11.45B	6.18%11.2B	5.59%11B	4.09%42.89B	7.71%11.42B	3.13%10.51B
Cost of revenue	13.04%9.18B	9.43%8.91B	7.74%33.63B	4.42%8.98B	9.04%8.38B	6.56%8.12B	11.50%8.15B	5.47%31.22B	10.60%8.6B	4.07%7.69B
Gross profit	3.64%3.19B	6.28%3.03B	2.76%11.99B	6.23%3B	8.91%3.07B	5.27%3.08B	-8.33%2.85B	0.58%11.67B	-0.21%2.82B	0.64%2.82B
Operating expense	24.81%2.61B	27.01%2.62B	17.22%9B	27.52%2.56B	16.26%2.29B	10.63%2.09B	13.77%2.07B	8.47%7.68B	7.97%2.01B	9.76%1.97B
Operating profit	-41.40%576M	-48.22%407M	-25.08%2.99B	-46.02%441M	-8.13%780M	-4.56%983M	-39.31%786M	-11.78%3.99B	-15.86%817M	-15.61%849M
Net non-operating interest income (expenses)	0.00%1M	-40.00%3M	-20.00%20M	0.00%3M	266.67%11M	-85.71%1M	-58.33%5M	19.05%25M	0.00%3M	-50.00%3M
Non-operating interest income	250.00%14M	28.57%9M	19.35%37M	66.67%10M	166.67%16M	-42.86%4M	-41.67%7M	47.62%31M	100.00%6M	0.00%6M
Non-operating interest expense	333.33%13M	200.00%6M	183.33%17M	133.33%7M	--5M	--3M	--2M	--6M	--3M	----
Net investment income	-1,500.00%-14M	59.26%-11M	13.33%-13M	266.67%11M	-71.43%2M	104.35%1M	-1,250.00%-27M	-287.50%-15M	150.00%3M	40.00%7M
Gain(Loss) on financial instruments designated as cash flow hedges	0	0	200.00%164M	0	-6M	103M	67M	-164M	-164M	0
Gain(Loss) on derecognition of available-for-sale financial assets	-47.83%-34M	54.05%-17M	-62.16%-60M	0	0	-64.29%-23M	-37M	64.76%-37M	23.33%-23M	0
Income from associates and other participating interests	-13M	-9M	51M			0	0	0
Special income (charges)	-2M	3M	-51M	-51M	0	0	0	0	0	0
Less:Other special charges	--2M	---3M	--51M	----	----	----	----	----	----	----
Other non-operating income (expenses)	14.29%16M	-20.00%16M	54.72%82M	111.76%36M	-47.83%12M	100.00%14M	233.33%20M	8.16%53M	142.86%17M	130.00%23M
Income before tax	-51.07%528M	-51.72%393M	-17.32%3.18B	-24.42%492M	-9.41%799M	7.26%1.08B	-37.96%814M	-10.13%3.85B	-29.62%651M	-11.98%882M
Income tax	-48.64%189M	-51.85%143M	-18.25%1.08B	-36.61%142M	-11.22%277M	5.75%368M	-32.81%297M	-9.43%1.33B	-28.66%224M	-9.04%312M
Net income	-52.53%338M	-51.55%250M	-16.84%2.1B	-17.84%350M	-8.60%521M	8.04%712M	-40.62%516M	-10.50%2.52B	-30.28%426M	-13.51%570M
Net income continuous operations	-52.32%339M	-51.64%250M	-16.83%2.1B	-18.03%350M	-8.42%522M	8.05%711M	-40.57%517M	-10.49%2.53B	-30.11%427M	-13.51%570M
Noncontrolling interests	60.00%8M	150.00%2M	633.33%16M	333.33%7M	8M	5M	-4M	-3M	-3M	0
Net income attributable to the company	-53.19%330M	-52.59%247M	-17.41%2.08B	-18.91%343M	-10.00%513M	6.98%705M	-40.05%521M	-10.60%2.52B	-30.77%423M	-13.51%570M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-53.19%330M	-52.59%247M	-17.41%2.08B	-18.91%343M	-10.00%513M	6.98%705M	-40.05%521M	-10.60%2.52B	-30.77%423M	-13.51%570M
Gross dividend payment
Basic earnings per share	-53.24%6.598	-52.48%4.952	-17.41%41.654	-18.98%6.864	-9.92%10.26	6.99%14.11	-40.05%10.42	-10.61%50.432	-30.75%8.472	-13.58%11.39
Diluted earnings per share	-53.21%6.598	-52.48%4.952	-17.41%41.654	-18.91%6.8601	-9.92%10.26	6.98%14.1002	-40.05%10.42	-10.61%50.432	-30.77%8.4601	-13.58%11.39
Dividend per share	0	0	0.00%5.044	0.00%5.044	0	0	0	-10.60%5.044	-10.60%5.044	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data